A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Towards harmonizing subtyping methods for neuroimaging studies in Alzheimer's disease
[article]
2020
medRxiv
pre-print
Biological subtypes in Alzheimer's disease (AD), originally identified on neuropathological data, have been translated to in vivo biomarkers such as structural magnetic resonance imaging (sMRI) and positron emission tomography (PET), to disentangle the heterogeneity within AD. Although there is methodological variability across studies, comparable characteristics of subtypes are reported at the group level. In this study, we investigated whether group-level similarities translate to
doi:10.1101/2020.04.19.20064881
fatcat:tzn47yajmzgh5m6lku72j53zgm